home

Company Snapshot

Read it, Learn it and Do it for your investment Needs
Daily market Tracker
Home > Market > Equity > Company Snapshot
Company Snapshot
Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code: 524804 NSE Symbol: AUROPHARMA P/E : 37.55
ISIN Demat: INE406A01037 Div & Yield %: 0 EPS : 36.91
Book Value: 369.16 Market Cap (Rs. Cr.): 80,504.91 Face Value : 1

Exchange

Stock Price Details
Last Price (₹) 1,392.00
Change 10.60 (0.77%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 1,367.20 - 1,392.00
52-Week Range 1,017.00 - 1,392.00
Beta (1 Year) 0.67
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap
Corporate Announcements
Aurobindo Pharma gets USFDA approval for Dapagliflozin & Metformin XR tablets
Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets
Aurobindo Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Aurobindo Pharma approves transfer of its generic formations products biz to Auropharm
Aurobindo Pharma board approves shares buyback of Rs 800 cr
Aurobindo Pharma fixes record date for buyback of shares
Aurobindo Pharma unveils share buyback plan worth Rs 800 crore
Eugia Pharma Specialities launches Pomalidomide Capsules in US market
Aurobindo Pharma launches Pomalidomide capsules in US market
Aurobindo Pharma arm receives 4 observations after US FDA inspection
Corporate Details
Incorporation Year : 1986
Chairman : M R Kumar
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :

Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana - 500038,
Phone : 91-40-23736370,
Fax : 91-40-23747340
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com
Investor Returns
Period Date Price(₹) Returns (%)
1Week 09-Apr-2026 1,339.50 3.48
1Month 16-Mar-2026 1,279.35 8.34
3Month 16-Jan-2026 1,172.30 18.24
6Month 16-Oct-2025 1,105.75 25.35
1Year 16-Apr-2025 1,132.80 22.36
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
HDFC Mid Cap Fund 2.04 1740.69
Quant ELSS Tax Saver Fund 7.97 875.30
Quant Mid Cap Fund 10.09 706.30
SBI Large & Midcap Fund 2.02 704.38
Quant Multi Cap Fund 8.52 560.17
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Sun Pharmaceutical Industries Ltd 1,693.15 -0.21 1,850.95 1,547.25 406,243.40
Lupin Ltd 2,326.50 -0.54 2,376.00 1,838.65 106,362.72
Dr Reddys Laboratories Ltd 1,221.25 0.24 1,377.95 1,121.20 101,932.48
Cipla Ltd 1,230.75 0.33 1,672.20 1,165.55 99,417.85
Zydus Lifesciences Ltd 939.20 0.34 1,059.00 813.00 94,505.50